Unexpected additive effects of minocycline and hydroxychloroquine in models of multiple sclerosis: Prospective combination treatment for progressive disease?
Simon Faissner(St. Josef-Hospital), V. Wee Yong(University of Calgary), Steffen Haupeltshofer(St. Josef-Hospital), Manoj K. Mishra(Alabama State University), Yasamin Mahjoub(University of Calgary), Tamir Ben‐Hur(Hebrew University of Jerusalem), Ralf Gold(University Hospitals of the Ruhr-University of Bochum), Jennifer Hahn(University of Calgary), Luanne M. Metz(University of Calgary), Marcus Koch(University of Calgary)
Cited by 37
Related Papers
Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway
|Brain|2011|1.2k
Dietary Fatty Acids Directly Impact Central Nervous System Autoimmunity via the Small Intestine
|Immunity|2015|919
Propionic Acid Shapes the Multiple Sclerosis Disease Course by an Immunomodulatory Mechanism
|Cell|2020|627
Progressive multiple sclerosis: from pathophysiology to therapeutic strategies
|Nature Reviews Drug Discovery|2019|456